In addition, miR-372 plays an oncogenic function by down-regulating fibroblast growth factor 9 (FGF9) and p62, respectively, in both lung squamous and head and neck squamous cell carcinoma [21,31]. This evidence concerns the gene FGF9 and head and neck squamous cell carcinoma.